FAST NEWS: Drug companies say they’re unaffected by Silicon Valley Bank failure
The latest: Several Hong Kong-listed pharmaceutical companies disclosed that they have deposits at U.S.-based Silicon Valley Bank (SVB), which was taken over by the Federal Deposit Insurance Corp. (FDIC) last…
BGNE.US
6160.HK
Recent Articles
RELATED ARTICLES
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
-
Yibin Bank’s IPO spotlights challenges facing regional lenders
2596.HK
-
BeiGene heads for profit milestone after hemorrhaging cash
6160.HK ONC.US 688235.SHG
-
Fanhua hits reset button, but has yet to say where exactly it’s going
AIFU.US
-
BRIEF: Everest unveils positive results for kidney drug EVER001 in Phase 1b/2a trial
1952.HK
Discover hidden China stock gems in our weekly newsletter